Naruse T - Search Results

Year	Number of Results
1963	4
1965	2
1966	7
1967	2
1968	5
1969	5
1970	5
1971	2
1972	2
1973	3
1975	1
1976	3
1977	5
1978	2
1980	2
1981	3
1982	5
1984	5
1985	4
1986	3
1987	3
1988	5
1989	8
1990	7
1991	11
1992	15
1993	24
1994	24
1995	14
1996	24
1997	23
1998	28
1999	22
2000	30
2001	15
2002	7
2003	5
2004	8
2005	7
2006	3
2007	15
2008	6
2009	13
2010	5
2011	14
2012	11
2013	19
2014	20
2015	28
2016	29
2017	25
2018	25
2019	14
2020	18
2021	16
2022	32
2023	27
2024	6

1

Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma.

Okuyama K, Naruse T, Yanamoto S. Okuyama K, et al. Among authors: naruse t. J Exp Clin Cancer Res. 2023 May 5;42(1):114. doi: 10.1186/s13046-023-02691-4. J Exp Clin Cancer Res. 2023. PMID: 37143088 Free PMC article. Review.

2

Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies.

Okuyama K, Fukushima H, Naruse T, Yanamoto S. Okuyama K, et al. Among authors: naruse t. Front Oncol. 2023 Sep 18;13:1248097. doi: 10.3389/fonc.2023.1248097. eCollection 2023. Front Oncol. 2023. PMID: 37790755 Free PMC article. Review.

3

Determination of a T cell receptor of potent CD8⁺ T cells against simian immunodeficiency virus infection in Burmese rhesus macaques.

Ishii H, Matsuoka S, Ikeda N, Kurihara K, Ueno T, Takiguchi M, Naruse TK, Kimura A, Yokoyama M, Sato H, Matano T. Ishii H, et al. Among authors: naruse tk. Biochem Biophys Res Commun. 2020 Jan 22;521(4):894-899. doi: 10.1016/j.bbrc.2019.10.196. Epub 2019 Nov 9. Biochem Biophys Res Commun. 2020. PMID: 31711644

4

Lead generation from N-[benzyl(4-phenylbutyl)carbamoyl]amino acid as a novel LPA₁ antagonist for the treatment of systemic sclerosis.

Kobayashi Y, Uneuchi F, Naruse T, Matsuda D, Okumura-Kitajima L, Kajiyama H, Wada R, Yonemoto Y, Nakano K, Toki H, Kamigaso S, Yamagishi J, Tokura S, Kakinuma H, Kuroda S. Kobayashi Y, et al. Among authors: naruse t. Eur J Med Chem. 2023 Nov 15;260:115749. doi: 10.1016/j.ejmech.2023.115749. Epub 2023 Aug 20. Eur J Med Chem. 2023. PMID: 37639822

5

Erratum: COLIN L. McLAY TOHRU NARUSE (2019) Revision of the shell-carrying crab genus Conchoecetes Stimpson, 1858 (Crustacea: Brachyura: Dromiidae). Zootaxa, 4706: 001-047.

McLAY CL, Naruse T. McLAY CL, et al. Among authors: naruse t. Zootaxa. 2020 Dec 4;4890(4):zootaxa.4890.4.11. doi: 10.11646/zootaxa.4890.4.11. Zootaxa. 2020. PMID: 33311113 No abstract available.

6

CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.

Kato S, Shida H, Okamura T, Zhang X, Miura T, Mukai T, Inoue M, Shu T, Naruse TK, Kimura A, Yasutomi Y, Matsuo K. Kato S, et al. Among authors: naruse tk. J Virol. 2021 Jan 28;95(4):e01718-20. doi: 10.1128/JVI.01718-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33087465 Free PMC article.

7

Redescription of Pinnixa haematosticta Sakai, 1934, its transfer to Indopinnixa Manning amp; Morton, 1987, and a reappraisal of Indopinnixa kumejima Naruse amp; Maenosono, 2012 (Decapoda: Brachyura: Pinnotheridae).

Komai T, Naruse T, Yokooka H, Taru M, Shimetsugu M, Watanabe T. Komai T, et al. Among authors: naruse t. Zootaxa. 2022 Feb 21;5100(3):361-389. doi: 10.11646/zootaxa.5100.3.3. Zootaxa. 2022. PMID: 35391070

8

Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.

Nomura T, Yamamoto H, Ishii H, Akari H, Naruse TK, Kimura A, Matano T. Nomura T, et al. Among authors: naruse tk. PLoS Pathog. 2015 Nov 4;11(11):e1005247. doi: 10.1371/journal.ppat.1005247. eCollection 2015. PLoS Pathog. 2015. PMID: 26536034 Free PMC article.

9

Duration of SARS-CoV-2 antigen positivity in hemodialysis patients.

Matsumoto J, Saka Y, Mimura T, Naruse T. Matsumoto J, et al. Among authors: naruse t. Ren Fail. 2022 Dec;44(1):11-13. doi: 10.1080/0886022X.2021.2013887. Ren Fail. 2022. PMID: 35094656 Free PMC article. No abstract available.

10

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab.

Tachinami H, Tomihara K, Yamada SI, Ikeda A, Imaue S, Hirai H, Nakai H, Sonoda T, Kurohara K, Yoshioka Y, Hasegawa T, Naruse T, Niiyama T, Shimane T, Ueda M, Yanamoto S, Akashi M, Umeda M, Kurita H, Miyazaki A, Arai N, Hayashi R, Noguchi M. Tachinami H, et al. Among authors: naruse t. Br J Oral Maxillofac Surg. 2023 May;61(4):320-326. doi: 10.1016/j.bjoms.2023.03.012. Epub 2023 Mar 31. Br J Oral Maxillofac Surg. 2023. PMID: 37061418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

626 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

626 results

Results by year